Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Regulatory Filings 2005

Dec 12, 2005

29831_rns_2005-12-12_7964e191-e85a-4042-8d0d-eee0c775c51d.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

8-K 1 pf8k1212.htm PFIZER INC. 8-K DEC. 12, 2005 Pfizer Inc. 8K -December 12, 2005

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report: December 12, 2005 Date of earliest event reported: December 12, 2005

PFIZER INC. (Exact name of registrant as specified in its charter)

Delaware 1-3619 13-5315170
(State or other Jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.)
235 East 42nd Street New York, New York (Address of principal executive offices) 10017 (Zip Code)

Registrant's telephone number, including area code:

(212) 573-2323

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions:

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

| Item 1.01 |
| --- |
| On September 22, 2005, the Board of Directors
of Pfizer Inc. approved the creation of the role of lead independent director
and elected Stanley O. Ikenberry to serve as the lead independent director
effective October 1, 2005. On December 12, 2005, the Board approved an annual retainer of $25,000
for the lead independent director. This retainer is in addition to the
other components of the Company’s compensation for non-employee
directors, which are described in the Company’s Proxy Statement
for the 2005 Annual Meeting of Shareholders. |

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

By: /s/ Margaret M. Foran Margaret M. Foran
Title: Senior Vice President - Corporate Governance, Associate
General Counsel and Secretary
Dated: December 12, 2005